| Year |
Citation |
Score |
| 2024 |
Roselle C, Horikawa I, Chen L, Kelly AR, Gonzales D, Da T, Wellhausen N, Rommel PC, Baker D, Suhoski M, Scholler J, O'Connor RS, Young RM, Harris CC, June CH. Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α. Proceedings of the National Academy of Sciences of the United States of America. 121: e2317735121. PMID 38408246 DOI: 10.1073/pnas.2317735121 |
0.6 |
|
| 2019 |
Stadtmauer EA, Cohen AD, Weber K, Lacey SF, Gonzalez VE, Melenhorst JJ, Fraietta JA, Plesa G, Shea J, Matlawski T, Cervini A, Mangan P, Gaymon A, Desjardins S, Lancaster E, ... ... Suhoski MM, et al. First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to Eliminate Endogenous TCR and PD-1 (NYCE T cells) in Advanced Multiple Myeloma (MM) and Sarcoma. Blood. 134: 49. PMID 31724015 DOI: 10.1182/Blood-2019-122374 |
0.396 |
|
| 2018 |
Svoboda J, Rheingold SR, Gill SI, Grupp SA, Lacey SF, Kulikovskaya I, Suhoski MM, Melenhorst JJ, Loudon B, Mato AR, Nasta SD, Landsburg DJ, Youngman MR, Levine BL, Porter DL, et al. Non-viral RNA chimeric antigen receptor modified T cells in patients with Hodgkin lymphoma. Blood. PMID 29925499 DOI: 10.1182/Blood-2018-03-837609 |
0.641 |
|
| 2015 |
Moraga I, Richter D, Wilmes S, Winkelmann H, Jude K, Thomas C, Suhoski MM, Engleman EG, Piehler J, Garcia KC. Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency. Science Signaling. 8: ra114. PMID 26554818 DOI: 10.1126/Scisignal.Aab2677 |
0.314 |
|
| 2013 |
Davidson MG, Alonso MN, Kenkel JA, Suhoski MM, González JC, Yuan R, Engleman EG. In vivo T cell activation induces the formation of CD209(+) PDL-2(+) dendritic cells. Plos One. 8: e76258. PMID 24098455 DOI: 10.1371/Journal.Pone.0076258 |
0.622 |
|
| 2013 |
Davidson MG, Alonso MN, Yuan R, Axtell RC, Kenkel JA, Suhoski MM, González JC, Steinman L, Engleman EG. Th17 cells induce Th1-polarizing monocyte-derived dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 191: 1175-87. PMID 23794631 DOI: 10.4049/Jimmunol.1203201 |
0.384 |
|
| 2013 |
Santegoets SJ, Turksma AW, Suhoski MM, Stam AG, Albelda SM, Hooijberg E, Scheper RJ, van den Eertwegh AJ, Gerritsen WR, Powell DJ, June CH, de Gruijl TD. IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells. Journal of Translational Medicine. 11: 37. PMID 23402380 DOI: 10.1186/1479-5876-11-37 |
0.657 |
|
| 2012 |
Junttila IS, Creusot RJ, Moraga I, Bates DL, Wong MT, Alonso MN, Suhoski MM, Lupardus P, Meier-Schellersheim M, Engleman EG, Utz PJ, Fathman CG, Paul WE, Garcia KC. Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nature Chemical Biology. 8: 990-8. PMID 23103943 DOI: 10.1038/Nchembio.1096 |
0.354 |
|
| 2012 |
Liu HH, Hu Y, Zheng M, Suhoski MM, Engleman EG, Dill DL, Hudnall M, Wang J, Spolski R, Leonard WJ, Peltz G. Cd14 SNPs regulate the innate immune response. Molecular Immunology. 51: 112-27. PMID 22445606 DOI: 10.1016/J.Molimm.2012.02.112 |
0.515 |
|
| 2011 |
Ye Q, Loisiou M, Levine BL, Suhoski MM, Riley JL, June CH, Coukos G, Powell DJ. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. Journal of Translational Medicine. 9: 131. PMID 21827675 DOI: 10.1186/1479-5876-9-131 |
0.658 |
|
| 2011 |
Alonso MN, Wong MT, Zhang AL, Winer D, Suhoski MM, Tolentino LL, Gaitan J, Davidson MG, Kung TH, Galel DM, Nadeau KC, Kim J, Utz PJ, Söderström K, Engleman EG. T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets. Blood. 118: 3311-20. PMID 21813450 DOI: 10.1182/Blood-2011-03-341065 |
0.475 |
|
| 2010 |
Paulos CM, Carpenito C, Plesa G, Suhoski MM, Varela-Rohena A, Golovina TN, Carroll RG, Riley JL, June CH. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Science Translational Medicine. 2: 55ra78. PMID 20980695 DOI: 10.1126/Scitranslmed.3000448 |
0.683 |
|
| 2010 |
Sluijter BJ, van den Hout MF, Stam AG, Lougheed SM, Suhoski MM, van den Eertwegh AJ, van den Tol MP, van Leeuwen PA, Meijer S, Scheper RJ, June CH, de Gruijl TD, Santegoets SJ. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes. Clinical Immunology (Orlando, Fla.). 137: 221-33. PMID 20708974 DOI: 10.1016/J.Clim.2010.07.009 |
0.684 |
|
| 2009 |
Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan DF, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proceedings of the National Academy of Sciences of the United States of America. 106: 3360-5. PMID 19211796 DOI: 10.1073/Pnas.0813101106 |
0.682 |
|
| 2008 |
Varela-Rohena A, Molloy PE, Dunn SM, Li Y, Suhoski MM, Carroll RG, Milicic A, Mahon T, Sutton DH, Laugel B, Moysey R, Cameron BJ, Vuidepot A, Purbhoo MA, Cole DK, et al. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nature Medicine. 14: 1390-5. PMID 18997777 DOI: 10.1038/Nm.1779 |
0.608 |
|
| 2008 |
Paulos CM, Suhoski MM, Plesa G, Jiang T, Basu S, Golovina TN, Jiang S, Aqui NA, Powell DJ, Levine BL, Carroll RG, Riley JL, June CH. Adoptive immunotherapy: good habits instilled at youth have long-term benefits. Immunologic Research. 42: 182-96. PMID 18949448 DOI: 10.1007/S12026-008-8070-9 |
0.552 |
|
| 2008 |
Golovina TN, Mikheeva T, Suhoski MM, Aqui NA, Tai VC, Shan X, Liu R, Balcarcel RR, Fisher N, Levine BL, Carroll RG, Warner N, Blazar BR, June CH, Riley JL. CD28 costimulation is essential for human T regulatory expansion and function. Journal of Immunology (Baltimore, Md. : 1950). 181: 2855-68. PMID 18684977 DOI: 10.4049/Jimmunol.181.4.2855 |
0.666 |
|
| 2008 |
Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, Bina M, Panoskaltsis-Mortari A, Rubinstein P, Van Rooijen N, Golovina TN, Suhoski MM, Miller JS, Wagner JE, June CH, et al. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood. 112: 2847-57. PMID 18645038 DOI: 10.1182/Blood-2008-01-132951 |
0.649 |
|
| 2008 |
Suhoski MM, Perez EE, Heltzer ML, Laney A, Shaffer LG, Saitta S, Nachman S, Spinner NB, June CH, Orange JS. Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells. Clinical Immunology (Orlando, Fla.). 128: 181-9. PMID 18511345 DOI: 10.1016/J.Clim.2008.03.522 |
0.621 |
|
| 2007 |
Zhang H, Snyder KM, Suhoski MM, Maus MV, Kapoor V, June CH, Mackall CL. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. Journal of Immunology (Baltimore, Md. : 1950). 179: 4910-8. PMID 17878391 DOI: 10.4049/Jimmunol.179.7.4910 |
0.698 |
|
| 2007 |
Banerjee PP, Pandey R, Zheng R, Suhoski MM, Monaco-Shawver L, Orange JS. Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse. The Journal of Experimental Medicine. 204: 2305-20. PMID 17785506 DOI: 10.1084/Jem.20061893 |
0.304 |
|
| 2007 |
Suhoski MM, Golovina TN, Aqui NA, Tai VC, Varela-Rohena A, Milone MC, Carroll RG, Riley JL, June CH. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 981-8. PMID 17375070 DOI: 10.1038/Mt.Sj.6300134 |
0.685 |
|
| Show low-probability matches. |